EpCAM from #pleural fluid cell lysates as diagnostic biomarker of adenocarcinomatous effusions-#Respirology https://t.co/kKvm4gqynO https://t.co/VbacqOEQ9B
Epithelial cell adhesion molecule (EpCAM) from pleural fluid cell lysates is a highly accurate diagnostic biomarker of adenocarcinomatous effusions.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Apr 2019 – Aug 2019Where it's discussed
-
X / Twitter10 posts
-
YouTube1 videos
AI synopsis
What people are saying
The discussions highlight the promise of EpCAM as a diagnostic tool, with posts mentioning its high sensitivity and specificity, such as 'EpCAM from cell lysates shows the highest accuracy,' and referencing its potential to improve diagnostic outcomes. The tone is professional but optimistic, reflecting a recognition of the article's relevance and potential impact on clinical practices.
Most discussions recognize the potential of EpCAM as a reliable biomarker for diagnosing malignant pleural effusions, indicating general support for the findings.
The posts show a moderate level of interest, with some emphasizing the clinical relevance and diagnostic improvements.
Participants engage by sharing links and mentioning the significance of the biomarker, suggesting they are considering practical applications.
The overall tone suggests that users see this research as having meaningful implications for diagnostic practices and future studies.
Abstract in brief
- The study evaluated three potential biomarkers in pleural fluid—EpCAM, claudin 4 (CL4), and HE4—to distinguish between malignant and benign effusions, with EpCAM from cell lysates (EpCAMcl) showing the highest accuracy.
- EpCAMcl demonstrated a sensitivity of 75%, specificity of 100%, and an area under the curve of 0.94 in detecting adenocarcinomatous effusions, making it a highly reliable diagnostic marker, especially when combined with immunostaining.
- Immunoassays for CL4 and HE4 were not effective for diagnosis, but EpCAMcl could correctly identify about one-third of false-negative cytology cases, highlighting its potential as a valuable biomarker for epithelial malignancies in pleural fluid.]
Top posts
Most liked on X and BlueskyEpCAM for diagnosing malignant effusions https://t.co/GZQjiOSvAK via @YouTube
Don't miss the Editor's Choice selection with FREE access in the new #Respirology issue 24/8 (August 2019) online: https://t.co/ysGzM8ZCFG & https://t.co/wxVFazblTC #EditorsFeature https://t.co/jDASan6EhN
Don't miss the Editor's Choice selection with FREE access in the new #Respirology issue 24/8 (August 2019) online: https://t.co/ysGzM8I1O8 & https://t.co/wxVFazsXic #EditorsFeature https://t.co/uYhh3gg6eO
RT @RespirologyAPSR: Don't miss the Editor's Choice selection with FREE access in the new #Respirology issue 24/8 (August 2019) online: ht…
RT @RespirologyAPSR: Don't miss the Editor's Choice selection with FREE access in the new #Respirology issue 24/8 (August 2019) online: ht…
All mentions
EpCAM as a Reliable Biomarker for Diagnosing Malignant Effusions
EpCAM from pleural fluid cell lysates is a highly accurate diagnostic biomarker for adenocarcinomatous effusions. The study shows that its quantification via immunoassays outperforms classical immunostainings, providing…
RT @RespirologyAPSR: Don't miss the Editor's Choice selection with FREE access in the new #Respirology issue 24/8 (August 2019) online: ht…
RT @RespirologyAPSR: Don't miss the Editor's Choice selection with FREE access in the new #Respirology issue 24/8 (August 2019) online: ht…
Don't miss the Editor's Choice selection with FREE access in the new #Respirology issue 24/8 (August 2019) online: https://t.co/ysGzM8I1O8 & https://t.co/wxVFazsXic #EditorsFeature https://t.co/uYhh3gg6eO
RT @RespirologyAPSR: Don't miss the Editor's Choice selection with FREE access in the new #Respirology issue 24/8 (August 2019) online: ht…
Don't miss the Editor's Choice selection with FREE access in the new #Respirology issue 24/8 (August 2019) online: https://t.co/ysGzM8ZCFG & https://t.co/wxVFazblTC #EditorsFeature https://t.co/jDASan6EhN
EpCAM for diagnosing malignant effusions https://t.co/GZQjiOSvAK via @YouTube
RT @RespirologyAPSR: EpCAM from #pleural fluid cell lysates as diagnostic biomarker of adenocarcinomatous effusions-#Respirology https://t.…
RT @RespirologyAPSR: EpCAM from #pleural fluid cell lysates as diagnostic biomarker of adenocarcinomatous effusions-#Respirology https://t.…
RT @RespirologyAPSR: EpCAM from #pleural fluid cell lysates as diagnostic biomarker of adenocarcinomatous effusions-#Respirology https://t.…
EpCAM from #pleural fluid cell lysates as diagnostic biomarker of adenocarcinomatous effusions-#Respirology https://t.co/kKvm4gqynO https://t.co/VbacqOEQ9B
R
AR
N
CC
PB